To test our hypothesis, we not only assessed the correlation between the expression of the newly identified JAK3-INSL3 fusion transcript with clinical data from SS patients, but also conducted in vitro and in vivo experiments with established CTCL cell lines. The gene discussed is INSL3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.